Teladoc Health Inc. (TDOC)
Teladoc Health Statistics
Share Statistics
Teladoc Health has 173.67M shares outstanding. The number of shares has increased by 3.07% in one year.
Shares Outstanding | 173.67M |
Shares Change (YoY) | 3.07% |
Shares Change (QoQ) | 0.55% |
Owned by Institutions (%) | 75.02% |
Shares Floating | 171.88M |
Failed to Deliver (FTD) Shares | 6.26K |
FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 23.5M, so 13.65% of the outstanding shares have been sold short.
Short Interest | 23.5M |
Short % of Shares Out | 13.65% |
Short % of Float | 13.94% |
Short Ratio (days to cover) | 5.57 |
Valuation Ratios
The PE ratio is -1.55 and the forward PE ratio is -10.04. Teladoc Health's PEG ratio is 0.
PE Ratio | -1.55 |
Forward PE | -10.04 |
PS Ratio | 0.6 |
Forward PS | 0.5 |
PB Ratio | 1.04 |
P/FCF Ratio | 5.48 |
PEG Ratio | 0 |
Enterprise Valuation
Teladoc Health Inc. has an Enterprise Value (EV) of 4.02B.
EV / Earnings | -4.01 |
EV / Sales | 1.56 |
EV / EBITDA | -6.84 |
EV / EBIT | -3.93 |
EV / FCF | 14.19 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.
Current Ratio | 1.77 |
Quick Ratio | 1.73 |
Debt / Equity | 1.06 |
Total Debt / Capitalization | 51.52 |
Cash Flow / Debt | 0.19 |
Interest Coverage | -42.89 |
Financial Efficiency
Return on equity (ROE) is -0.67% and return on capital (ROIC) is -33.45%.
Return on Equity (ROE) | -0.67% |
Return on Assets (ROA) | -0.28% |
Return on Capital (ROIC) | -33.45% |
Revenue Per Employee | $556,184.85 |
Profits Per Employee | $-216,719.7 |
Employee Count | 4,620 |
Asset Turnover | 0.73 |
Inventory Turnover | 19.7 |
Taxes
Income Tax | 7.59M |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -43.38% in the last 52 weeks. The beta is 1.27, so Teladoc Health's price volatility has been higher than the market average.
Beta | 1.27 |
52-Week Price Change | -43.38% |
50-Day Moving Average | 10.27 |
200-Day Moving Average | 9.4 |
Relative Strength Index (RSI) | 39.95 |
Average Volume (20 Days) | 7.65M |
Income Statement
In the last 12 months, Teladoc Health had revenue of 2.57B and earned -1B in profits. Earnings per share was -5.87.
Revenue | 2.57B |
Gross Profit | 1.82B |
Operating Income | -1.02B |
Net Income | -1B |
EBITDA | -587.01M |
EBIT | -1.02B |
Earnings Per Share (EPS) | -5.87 |
Balance Sheet
The company has 1.3B in cash and 1.58B in debt, giving a net cash position of -286.29M.
Cash & Cash Equivalents | 1.3B |
Total Debt | 1.58B |
Net Cash | -286.29M |
Retained Earnings | -16.23B |
Total Assets | 3.52B |
Working Capital | 722.37M |
Cash Flow
In the last 12 months, operating cash flow was 293.68M and capital expenditures -10.79M, giving a free cash flow of 282.89M.
Operating Cash Flow | 293.68M |
Capital Expenditures | -10.79M |
Free Cash Flow | 282.89M |
FCF Per Share | 1.66 |
Margins
Gross margin is 70.76%, with operating and profit margins of -39.73% and -38.97%.
Gross Margin | 70.76% |
Operating Margin | -39.73% |
Pretax Margin | -38.67% |
Profit Margin | -38.97% |
EBITDA Margin | -22.84% |
EBIT Margin | -39.73% |
FCF Margin | 11.01% |
Dividends & Yields
TDOC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -68.65% |
FCF Yield | 19.05% |
Analyst Forecast
The average price target for TDOC is $11, which is 28.7% higher than the current price. The consensus rating is "Hold".
Price Target | $11 |
Price Target Difference | 28.7% |
Analyst Consensus | Hold |
Analyst Count | 18 |
Scores
Altman Z-Score | -5.95 |
Piotroski F-Score | 3 |